Dr. Abram D. Tipton

Arthur Delahoussaye is an Ophthalmologist in Houma, Louisiana. Dr. Delahoussaye is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa, Cone Dystrophy, and Cone-Rod Dystrophy. Dr. Delahoussaye is currently accepting new patients.

Dr. Anthony Mazzulla is an ophthalmologist specializing in retina and vitreous surgery. He was born in Oak Park, Illinois and his interest in eye disease began at an early age. Dr. Mazzulla comes from a family of eye care professionals, and his father and older sister are both optometrists. He obtained his bachelor's degree with honors and his medical degree from the University of Illinois at Chicago as part of the combined medical program, Guaranteed Professional Program Admissions (GPPA). He completed his transitional year internship at West Suburban Hospital in Oak Park, IL. He went on to complete a three-year residency in ophthalmology at the University of Chicago. Dr. Mazzulla is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Retinal Artery Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Vitrectomy.

Dr. Creed received his undergraduate degree from LSU in Baton Rouge and earned his medical degree from LSU in New Orleans, where he was President of the American Medical Association Student Chapter, Aesculapian Honor Society. He completed an externship at the American Hospital of Paris in Neuilly, France. After his internship and ophthalmology residency at Ochsner, he completed a retina and vitreous fellowship at Piedmont Hospital in Atlanta, Georgia. Dr. Creed is board certified in ophthalmology and has been on staff at Ochsner since 2001. Dr. Creed is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Artery Occlusion.